Please login to the form below

Not currently logged in
Email:
Password:

alocirumab

This page shows the latest alocirumab news and features for those working in and with pharma, biotech and healthcare.

Amgen throws its hat into the cholesterol antibody ring

Amgen throws its hat into the cholesterol antibody ring

News that the results were positive sets up an interesting battle between Amgen and Regeneron/Sanofi - whose alocirumab (REGN727) candidate produced impressive results in a phase III trial reported in October -

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics